| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 155.95B | 159.03B | 159.23B | 135.01B | 124.08B | 83.42B |
| Gross Profit | 33.73B | 36.18B | 36.31B | 22.92B | 15.01B | -4.13B |
| EBITDA | 30.14B | 31.91B | 32.91B | 20.08B | 13.17B | -5.58B |
| Net Income | 21.11B | 21.59B | 26.25B | 19.95B | 11.19B | -8.42B |
Balance Sheet | ||||||
| Total Assets | 222.38B | 266.15B | 209.04B | 174.79B | 124.90B | 123.72B |
| Cash, Cash Equivalents and Short-Term Investments | 99.91B | 121.72B | 90.14B | 55.39B | 29.46B | 25.28B |
| Total Debt | 17.62B | 21.32B | 18.51B | 13.57B | 11.87B | 15.33B |
| Total Liabilities | 112.18B | 128.71B | 103.89B | 94.89B | 74.84B | 86.55B |
| Stockholders Equity | 109.82B | 137.44B | 104.76B | 79.68B | 49.96B | 37.17B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 32.09B | 32.42B | 25.61B | 7.10B | 13.65B |
| Operating Cash Flow | 0.00 | 38.85B | 37.73B | 27.41B | 9.00B | 15.10B |
| Investing Cash Flow | 0.00 | -9.81B | -5.26B | -1.92B | -1.26B | -715.00M |
| Financing Cash Flow | 0.00 | -500.00M | 2.29B | 571.00M | -3.38B | -2.50B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥142.14B | 12.53 | 9.14% | 2.84% | 6.97% | 28.34% | |
70 Outperform | ¥239.27B | 11.89 | 16.64% | 1.36% | -0.12% | -17.83% | |
64 Neutral | ¥15.68B | 7.06 | ― | 0.27% | 5.30% | 126.07% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
59 Neutral | ¥417.74B | 11.17 | 13.69% | 0.60% | 12.09% | -1.60% | |
59 Neutral | ¥218.76B | 20.35 | ― | 2.41% | 5.68% | -49.64% | |
52 Neutral | ¥3.23B | 17.83 | ― | 0.67% | 6.22% | 385.27% |